Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,258,614
-
Total 13F shares
-
1,382,434
-
Share change
-
+54,743
-
Total reported value
-
$2,197,000
-
Price per share
-
$1.59
-
Number of holders
-
15
-
Value change
-
+$44,107
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q1 2020
As of 31 Mar 2020,
Anixa Biosciences Inc - Common Stock (ANIX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,382,434 shares.
The largest 10 holders included
VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, SEGALL BRYANT & HAMILL, LLC, MORGAN STANLEY, and RAYMOND JAMES & ASSOCIATES.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.